The Foundation for the National Institutes of Health Appoints Love Collins, III to Lead Advancement and Development

NORTH BETHESDA, Md., May 13, 2024 — The Foundation for the National Institutes of Health (FNIH) announces that Love Collins, III, has joined as Vice President of Advancement. In this role, he will serve as the FNIH’s chief development officer and will lead efforts to expand the portfolio of resources and help accelerate the launch of new collaborative biomedical research programs and related scientific efforts in support of the NIH.

“We are delighted that Mr. Collins is joining the FNIH team,” said Julie Gerberding, MD, MPH, President and CEO of the FNIH. “As our chief development officer, his experience in establishing trustworthy relations with research investors and philanthropists aligns perfectly with our mission and will help catalyze the resources we need to expand the scope and impact of our scientific portfolio.”

“I am honored to be a part of the exceptionally talented team at the FNIH,” said Mr. Collins. “The FNIH is an amazing organization, and I welcome the chance to help expand its public-private partnerships that tackle the complex health challenges that no single organization can solve on its own. Breakthroughs require resources and trustworthy relationships, and I look forward to contributing to both.”

With more than 30 years of experience in both the public and private sectors, Mr. Collins has extensive expertise in fundraising, strategic planning, and organizational development, with particular emphasis in biomedical research and health science philanthropy. He has successfully raised over $500 million for a diverse range of nonprofit organizations.

Mr. Collins served as Vice Chancellor of Development and Alumni Affairs at the University of Tennessee Health Science Center, where he led a team in raising over $100 million in philanthropic support. Mr. Collins also served as Vice President of Development and Communications at the Van Andel Institute, where he increased annual fundraising from $2 million to $7 million in support of translational science and breakthrough research in cancer, Parkinson’s disease, and epigenetics.

Mr. Collins’ career includes top leadership roles at institutions such as Dillard University, Benedict College, Howard University, Florida A&M University and Foundation, and the 1996 Atlanta Committee for the Olympic Games, where he served as deputy managing director of operations.

Mr. Collins holds a bachelor’s degree in engineering from the U.S. Military Academy at West Point and an MBA in finance from Emory University, Goizueta Business School.

About the Foundation for the National Institutes of Health
The Foundation for the National Institutes of Health (FNIH) builds public-private partnerships that connect leading biomedical scientists at the National Institutes of Health (NIH) with their counterparts in life sciences companies, academia, patient organizations, foundations, and regulatory agencies (including the Food and Drug Administration and European Medicines Agency). Through team science, the FNIH solves complex health challenges and accelerates breakthroughs for patients, regardless of who they are or what health threats they face. The FNIH contributes to the development of new therapies, diagnostics, and potential cures; advances global health and equity in care; and celebrates and helps train the next generations of scientists. Established by Congress in 1990 to support the mission of the NIH, the FNIH is a not-for-profit 501(c)(3) charitable organization. For more information about the FNIH, please visit

Follow us on social media: LinkedIn, X, Facebook.